Secondary Prevention of Coronary Disease with ACE Inhibition-does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?

By Remme Willem   Deckers Jaap   Fox Kim   Ferrari Roberto   Bertrand Michel   Simoons Maarten  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 161-170

Springer Publishing Company

Access to resources Recommend Favorite

ACE Inhibition with Moexipril: A Review of Potential Effects Beyond Blood Pressure Control

By Pines A.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 5, 2003-01 ,pp. : 351-360

Adis International

Access to resources Recommend Favorite

Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

By Kjeldsen Sverre E   Lyle Paulette A   Tershakovec Andrew M   Devereux Richard B   Oparil Suzanne   Dahlöf Björn   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Kristianson Krister   Lederballe-Pedersen Ole   Lindholm Lars H   Nieminen Markku S   Omvik Per   Wedel Hans  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 729-745

Informa Healthcare

Access to resources Recommend Favorite

Effects of Blood Pressure Control in Cardiovascular Prevention

By  

Current Pharmaceutical Design, Vol. 22, Iss. 37, 2016-10 ,pp. : 5649-5661

Bentham Science Publishers

Access to resources Recommend Favorite

Renin-Angiotensin Antagonists: Therapeutic Effects Beyond Blood Pressure Control?

By  

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 1011-1020

Bentham Science Publishers

Access to resources Recommend Favorite